reverse these electrophysiological changes observed after which closely corresponds with AERP, may contain progexperimental [3] , induced [4] or chronic AF [9] . At this nostic information in patients undergoing cardioversion point in time, the resolution course of these changes and its with ibutilide, a selective class III antiarrhythmic agent relation with arrhythmia recurrence were unknown.
that prolongs MAP and AERP. Two independent studies In this issue of Cardiovascular Research Manios and identified an atrial cycle length of 160 ms obtained from colleagues [10] for a successful cardioversion. Patients with short cycle leads to a shortening of both AERP and MAP duration, an lengths had a low chance of drug-induced conversion abnormal adaptation of repolarisation to rate and slowing while longer cycle lengths were associated with a higher of conduction as expressed by prolongation of the P wave success rate. on the surface ECG. The reversibility of the atrial electrical While the latter studies assessed fibrillatory cycle length remodeling process was analyzed in detail. This study prior to the intervention Manios et al., similar to the represents the largest analysis of this kind with observaOlsson study, determined atrial electrical parameters imtions obtained from three serial stimulation procedures.
mediately after cardioversion. They found that patients While AERP and MAP duration returned to values comwho failed to shorten the MAP to values less then 195 ms parable to those obtained from normals within 24 h at a pacing cycle length of 350 ms were more likely to following restoration of sinus rhythm, P wave duration have AF recurrence. This finding was explained by a more exhibited a slower resolution course. Finally, the authors abnormal rate adaptation curve, which is in agreement to identified MAP duration at short pacing cycle lengths to be an early study performed by Attuel and colleagues showa predictor for early AF recurrence following cardiovering that poor or absent rate adaptation of AERP is related sion.
with vulnerability to AF [24] . There is substantial interindividual variability in the Since there is a strong intercorrelation between MAP atrial electrophysiologic state. AF treatment is, however, duration, AERP as well as atrial fibrillatory cycle length, based on trial and error, since no test is able to predict the and subsequently AF organisation and complexity it may natural history of this arrhythmia or its response to be possible to quantify the individual AF-induced electrical treatment. The most common parameter used to guide changes by one or more of these measures. therapy is left atrial size even though its role for prediction
The major contribution of Manios' study is that it of outcome following cardioversion is controversial. While strengthens our knowledge of the atrial electrical remodelsome investigators have found higher AF recurrence rates ing process and especially its reversibility in chronic AF. It in patients with left atrial enlargement [11, 12] others have demonstrates the relation between atrial electrical propnot [13] [14] [15] .
erties on a patient-by-patient basis and outcome which may As the number of therapeutic options including new be of great importance to select among the various antiarrhythmic drugs or non-pharmacologically approaches therapeutic approaches. (ablation, implantable atrial defibrillator, pacing) increases, there is a clear need for tests that quantify the atrial electrical remodeling and subsequently guide AF manageReferences ment.
Only few studies, so far, have investigated the relation patients who maintained sinus rhythm for over 3 months 
